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Dear Dr. Orosz: 
I read your beautifully wrirten Hume 
lecture (Orosz eG. Immunomvthology of 
trans plan ta tion. Graft 1: 175-180.1998). 
There is very little in it that I would want to 
debate. Although the reductionist approach 
has served science well since the time of 
Francis Bacon, you have brilliantly identitied 
irs weaknesses. I was especially raken bv your 
sections on phylogenies and scaffolding. 
What IS your maste r swi tc h". 
Zinkernagel and I defined this in terms of 
antigen migration and localization (reprint 
enclosed), rarher theln by some discrete 
effector mechanism. Except for emphasis. 
however. our position (derived exclusively 
from in vivo observations) and yours make a 
remarkable fit. 
Although we have accepted parasitiC 
microorganisms as the evolutionary drive I'Jr 
development of the immune svstem, I'OU 
were WI" to imply other possibilities. Helving 
g'lIned the impression somewhere that the 
pathologist, ;"1etchnikoff. (also ,In 
embrvologist) suspected a deve\op-ment,d 
roie. I tried a year or so ago to obtain 
,onlirm,!(ion frOIll Metchnikoff's hiographn, 
Fred Tauber (Metchnikoff and the Origins ot 
Immunology: from metaphor to theory. I l)l) I 
Oxford Univer.sity Press); TdLlber did not 
think so. 
However, abour 50 years ago, Crobstein 
summarized ('vidence of mesenchymal -> 
<'pitheli'll signaling as an essen rial control in 
the shaping of tissues and organs (Crobstein 
C: Mechanisms of Organogenetic Tissue 
Interauion. ;\',uional C,/ncer Illstlll/le 
Monograph 2(,:279-299, 1967). Unmistakable 
molecubr evidence of this has come from the 
German laboratories of Birchmeier (see 
Sonnen bert et al: Scaner factor/ hepatocyte 
growrh factor and its receptor, the C-Illet 
tyrosine kinase. can mediate a signal exchange 
between mesenchymal and epithelia during 
mouse development. J Cell Biology 123:223-
235.1993). 
It is no surprise that a number of 
"homeobox" (regulatory) genes have been 
described in the last 3 or 4 years (e.g. see B. 
Hen tsch et al: H I x homeobox gene is 
e"ential for an inductive tissue interaction 
that drives expansion of embryonic liver and 
gut. Genes & Development 1 0:70-79. 1995) 
th,j( appear to regulate the organogenesis of 
upper limbs. lower limbs, thoracic organs 
.Ind the hepato-intestinal complex. If the 
.llliage of the immune system is involved, 
this might be called "non-immunologic" 
function of the immune system components 
that you hinted at. It could be a semantic 
distinction. 
Liver regeneration, following partial 
hepatic resection or transplantation of "small 
tor recipient size" allografts is a good example 
of recapitulation In adult life of 
organogenesis and organ shaping. I began a 
search more than 35 years ago for the 
molecules controlling this and. ended up with 
.I family of eight hepatotrophic and two 
.lflrihepatotrophic factors. all of which also 
,llrect Immune function. All, including the 
product of the ALR gene that we discovered, 
[1[ofoundly influence regeneration. and 
,everal He now formallv cLlssified as 
'l,tokines (e.g. hepatocyte growth ElCtor). 
Along potentially related lines, 
Rinkevich (an oceanographer from Haifa) 
who frequently collaborates with Irving 
\X'cissman [Stanford], has been studying a 
pro-vertebrate (runicate) which in ontogeny 
goes through an abortive notochord phase. 
The runicate has a single 1\.1HC haplotype 
(called "a fusibility/histocompatibility locus") 
that controls the fusion and establishment of 
a common circulation (analogous to Owen's 
freemartin catrle) that is necessary for 
the formation of the jellyfish colonies that 
,Ire necessary for their unpleasant community 
,urvival (thev plague sea-side beaches). 
Rather than being defensive against 
parasites. their primitive immune system 
(with its adaptive qualities) seems geared 
more to ensure species homogeneity. 
However, even if the immune system served 
quite different (from anti-parasitic) purposes 
at the beginning of evolution, failure to 
evolve further to meet the defensive needs 
would have doomed the increasingly complex 
multicellular organisms to prompt 
extinction. Thus, these roles (i.e. growth and 
antimicroorganism) are not mutually 
exclusive. 
[n any event. your paper in Grafl is 
going to spark mllch discussion. I will be 
interested to see where you go from here. You 
might want to peruse the book by John 
Horgan which attempts to debunk the chaos 
and complexity concepts ("The End of 
Science", John Horgan. Broadway Books 
1997). In contrast, "The Frontiers of 
Complexitv" by Peter Coveney and Roger 
Highfield is sterling defense of complexity 
ideas (Ballantine Books, Random House, 
I ')9)). The recent book by former editor in 
chief of Nil/lire (John Maddox. Random 
House. 1996) is another example. A review of 
the Maddox book is in the January 10. 1999 
New }ork Times. 
Thomas E. Starzl. M.D., Ph.D. 
Profe"or of Surgery 
University of PittSburgh 
Dear Dr. Starzl: 
Thank you for your letter of January 
7th, and for the kind compliments that it 
contained regarding the content of the Humc 
Lecture. I "came out of the closet" with the 
publication of the lecture in Graft. I no 
longer live a double life as I continue to 
develop my nOl1col1ventional views on the 
immunobiology of transplantation. I feel 
both liberated and exhilarated by the 
intellectual risk of stepping beyond the limits 
of conventional thought. While this is an 
experience that you have had many times 
during your career. it is all quite new to me. 
The breadth of the comments in your 
scholarly letter will require considerable 
thought on my parr. but I would like [0 
address one or rwo issues that vour letter has 
already raised in my mind. You asked about a 
"master switch." I cannot answer this 
question without defining the context of the 
biologic process that I envision. I have 
followed the conceptual developments that 
you have provided in papers co-authored 
with Rolf Zinkernagel. and I believe that 
there exists a fundamental difference between 
our conceptualizations and my own. Your 
views are decidedly T cell-centric, and 
reminiscent of the Gershonian orchestra in 
which all members of both the orchestra and 
the audience are focused intently on the 
venerable conductor. the T cell. The curtain 
rises in the presence of antigen, the 
performance is over when the antigen has 
been eradicated. and evervone goes home ro 
await another performance. 
In contrast, I prefer a more Copernican 
view in which the T cell at an inflammatory 
site is JUSt one of many satellites orbiting 
around a local sun, the macrophage. The 
macrophage is but a small part of the 
immunologic galaxy (including lymphoid 
organs and other immune response sites) 
which, in turn, is imbedded in the cosmos of 
physiology. In this cosmology, tissue 
inflammation, immunity and repair are 
phases of a single, seamless process managed 
by macrophages. These macro phages are 
adept at using T cells, B cells (lg), NK cells 
(and probably many other cell types, 
including endothelial cells and parenchymal 
cells), all operating in parallel, to generate 
accurate information regarding the nature of 
the evolving problem posed co the immune 
system at a site of tissue damage or foreign 
molecule expression. The master switches are 
the biochemical mechanisms that promote 
the transitions from one phase to the next 
during the response process. In this context, 
antigen engagement by T cells is just another 
piece of information processed by 
macrophages during the decision-making 
process. Thus, TGFp, for example, acts as a 
master switch co proceed from one complex 
array of processes to another. i.e., from 
immunitv to tissue repair. How thesl.' 
switches are thrown is far from clear. 
More importantly, I believe that these 
phenomena constitute on 11' a small parr of 
immune function. In general. I believe thar 
the immune system is a cognitive device that 
constantly monitors the state of the internal 
environment. Irs job is to make decisions Oil 
how best to avoid phvsiologic disruption and 
maintain homeostasis while interacting 
intimately with the external environment. 
Many (mavbe most) times. the decision 
favors incorporation of foreign molecules 
into the physiologic meshwork. rarher rhan 
their eradication. (Simple ignorance of 
foreign molecules is probably too ri,b' to bl.' 
a viable choice for the immune system). In 
places like the gut Jnd respirator;· traer, 
incorporation is probably favored. unless the 
foreign molecules arc obviouslv disruptiVl' 
(cause cell malfunction or tissue damagt')' 
Indeed. engagement of the eradicarion 
mechanisms is inherently dangerolls. sinCl' 
these mechanisms also dlsrupr loul 
physiology. In contrast. when forclgll 
antigens are placed within the skin. thn 
usually evoke the opposite im mune deciSion. 
eradication. Our primary challenge \.s to 
determine how these different immunologiL 
decisions arc made. In this contexr. the eVI.'l 
more sophisticated examinatwn of 
mechanisms by which antigen is eradlc.H,·d 
pales in importance. Nevertheless. If we 
choose ro study the eradication mechanisms. 
we should not ignore the counterbalanCing 
acceptance mechanisms, nor should we trColt 
them as if they were separate immunologi, 
entities. This series of considerations retleets 
the point that you made in your letter "bou r 
tunicates, which use their "MHC" for 
acceptance responses in the development of 
jellyfish colonies. 
I appreciate the suggestions in your last 
paragraph regarding suggested readings. 
Indeed. I have read Horgan's book "The End 
of Science." In general. I accept his premise as 
plausible. The role of science in our culture, 
as well as the way that it is practiced, arc 
clearly changing ("continue to evolye" would 
be a better way to put it). I found "The 
Frontiers of Complexity" to be a reasonable 
introductory work about the many facets of 
complexity theory, although not one of the 
best. The best book that I have ever read on 
the topic was the least technical. Kevin Kellv's 
"Out of Control." It is fun to read, 
fascinating and instructional. I have taken the 
liberty of enclosing a copy with this letter. I 
hope that you enjoy it as much as I have. I've 
already reread it twice. I especially like the 
first 7 chapters which discuss the principles of 
networked systems, and chapter J 4. which 
describes the fascinating concept of the 
Borgian library. If you have already read the 
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book. please fcel free [0 pass it on to one of 
your fellow theoreticians. 
hnallv. I would like to leave vou with 
one IIltercsting idea. I mentioned earlier that 
w"should learn how the immune system 
makes decision;. I suggest that important 
clue.s may lie in the realm of game theory, a 
subdiscipline o[complexity theory. In the late 
I ')Lj(h. a computer program was developed 
rh.1I allowed a compurer to learn how to win 
.It checkers. The computer was not 
preprogrammed with all possible moves for 
all possible situations. Rather. it was provided 
with a few rules that allowed it to evaluate the 
current (and unpredictable) configuration of 
the board at each step of play. and choose the 
most effective move. The principles on which 
this program was developed are startlingly 
1!1sightful. and seem quite applicable ro the 
immune system. If you are interested in this 
ideal. you will find game theory discussed in 
a book by John Holland called "Emergence: 
horn Chaos to Order" published in J 998 by 
Addison-Wesley Publishing Company. 
Thank you once again for your 
stimulating letter and your encouraging 
comments. 
Charles G. Orosz, PhD 
Department of Surgery 
Ohio State University 
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If you think that you know the 
answers, you probably don't 
appreciate the nature of the problem. 
would like to thank the American 
Society of Transplant Surgeons, 
and especially its President, Dr. 
Ronald Ferguson, for the honor of deliver-
ing this year's Hume Lecture. 
As most of you know. I am a Ph.D. and an 
Immunologist who adopted transplantation 
in the early 80's. My obsession with this disci-
pline developed directly from a series of colla-
borative studies that I undertook with Ron 
Ferguson regarding the functional actlvitie~ 
of cloned T cells when they were under the 
influence of a newly discovered drug. then 
called Cyclosporin A. 
For perspective. I should tell you that I con-
sider the field of Transplantation to be cur-
rently in its mid-to-Iate adolescence. reco-
gnizable as an unique entity but still some-
what immature. In this context. I consider the 
changes that I referred to a few minutes ago to 
be but a few of the growing pains that the dis-
cipline will experience on its road to full 
maturity. When I first joined the business. in 
the early 19805. Transplantation was in its 
~arJy adolescence. I'd already missed its child-
hood. the era of first and second generation 
pioneers whose names are now legendary ,in 
the field. I find it quite humbling to note that 
several of these pioneers. including Sir Peter 
Medawar. Robert Good. and Thomas Starzl. 
have given Hume Lectures before me. By the 
time I arrived on the Transplant scene. the 
core surgical and therapeutic techniques had 
already been established. primarily on the 
basis of clinical empiricism. The role of the 
transplant investigator was to provide a scien-
tific foundation for these empiricisms. In 
those days. the primary obstructions ro trans-
plant success were infection and rejection. 
both conSIdered to be immunologic prob-
lems. Thus. investigators turned to Immunol-
ogy as the warehouse of information that 
would provide solutions to their problems. 
and. as we all know. Immunology has domi-
nated transplant research ever since. 
Interestingly, it is now clear in retrospect. 
that Immunology. despite i(5 vast scope and 
current state of complexity, is also a field in its 
mid-to-late adolescence_ In many ways, 
I mmunology and Transplantation are grow-
ing up together. In my experience. teenagers 
can be quite outspoken regarding their opin-
Ions on many of life's thornier problems. I 
often find these opinions to be different. 
interesnng. and sometimes even informative. 
I t seems that teenagers have been endowed 
with most of the answers. despite the fact that 
they have yet to fully appreciate the true 
nature and complexity of the real problems. 
As vou will see from the content of this talk. I 
believe that this is also true for the rwo ado-
lescents currentlv under consideration. Trans-
planta-tion and Immunology. 
In the old days 
I like to think of the 20-25 year span that 
began in the early 80's as the period in trans-
plant research during which I stood "my 
watch". Thus far on my watch. I have obser-
ved with great interest the continuing co-evo-
lution of transplantation and immunology. 
Both have become much more sophisticated. 
Both have become more politicized. and both 
have become more entrepreneurial. Neither 
look at all like the disciplines I joined almost 
20 years ago. 
Life as a transplant immunologist was 
much simpler then. It had become pretty 
obvious that T cells caused graft rejection. and 
that thev could be.divided into three func-
tional subsets: the now-famous CTL. which 
caused destruction of graft tissues. the equal-
Iv famous HTL. which somehow assisted in 
the generation of CTL. and the poor. untortu-
nale suppressor T cell. While the fame of the 
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CTL and HTL was spreading. suppressor T 
cells lingered near oblivion until only recent-
ly. when they have re-emerged. Phoenix-like. 
from studies on immunologic tolerance in 
several rodent models of disease. 
In those days •. the only known Interleukins 
were ILl and IL2. Cyclosporine was a new 
drug without a reputation. The MLR domi-
nated transplant research. and we relied heav-
ily on it to provide most of the information 
required to understand the processes of acute 
rejection. We needed merely to tie up a few 
loose ends and to assemble this growing body 
of in vitro information into patterns of 
immune activity that could be validated in 
vivo. when and if we got around to it. 
There was rampant optimism in the field. 
Specialty niches had been successfully carved 
out of both medicine and immunology. The 
intellectual land rush was on. We knew the 
key immunologic players. we knew how they 
worked. and we were learning how to control 
them. We were rapidly closing in on the 
answers. Interestingly, w~ had yet to learn 
about APCs and ~heir subtypes, TH 1 or TH2 
cdls;-arid muhitudes of cytokine~. chemo-
kines and adhesiol.1 molecules. The molecular 
structures of the TcR and of MHC molecules 
were still unknown. There were no signal 
transduction pathways. no lymphocyte-
endothelial interactions. no antigen process-
ing and presentation pathways. no costimula-
tor mechanisms. There was no molecular 
immunology, and gene therapy was Star Wars 
(itself a recent cinematic phenomenon). 
In many ways. these were the halcyon days 
of transplantation. There were only a few 
immunosuppressive agents to worry about: 
immuran. prednisone and ALG. Research 
funding for transplant-related studies was 
generally easy to get. and huge research labo-
ratories could be built and maintained soIeiv 
on the basis oi continuous NIH funding. 
Renal all~grafts dominated clinical transplant 
effons. and success was measured in simple 
ways. usually as rates of one year graft sur-
vival. Tissue typing labs were loose and-free-
wheeling. concerned with serologic identifica-
tion of new MHC alleles. pre-transplant sero-
logic testing. and whatever dse interested 
them. all of which was financed by the 
government. Most importantly. there was a 
tangible esprit-dc-corps that united all the 
clinical and research components of a Trans-
plant Program around the welfare of the indi-
vidual transplant patient. 
Where do we go wrong? 
So. what went wrong? Despite almost 50 
years of intense clinical and basic research. we 
still cannot define simple mechanisms of acute 
allograft rejection. Similarly. the mechanisms 
of chronic allograft rejection remain highly 
conjectural. and only recently have they even 
been addressed by the transplant research 
community. Pharmacologically-induced .ulo-
graft acceptance. (I decline ro use the argu-
mentative term "tolerance") has been achiev-
able in rodents for more than 15 years. but no 
coherent mechanism of allograft acceptance 
has yet been proposed. let alone applied [0 
clinical transplantation. Until recently. 
progress in experimental xenotransplantation 
was announced when graft survival was 
extended by a few minutes to a few hours. and 
now new mechanisms of rejection seem to 
appear as soon as the known mechanisms suc-
cumb [0 pharmacologic or genetic control. 
The question is: U7hy hav~ W~ bun so sptctacu-
i4r/y U7ISucctSsfol at tUftn;ng th~ m~chanisms of 
allograft rrymion. tsptcially afur all this IImt 
and t/fort? How have the answers to these 
seemingly simple questions managed to dude 
us so effectivdy for so long? 
I propose to you that this is the direct resul t 
of the fact that we still do not appreciate the 
true nature of the biologic and medical prob-
lems that we face. nor do we understand the 
true nature oflmmunology. the very tool that 
we rdy on to attack these problems. 
Pervasive complexity 
I believe that o~e important reason for this 
lack of ,!nderst~nd!ng is the sheer complexity 
-o~une function as we now know it. In an 
elm" tori~ °up a few loose ends. we have opened 
Pandora's box. The TcR turned out to be a 
multi-molecular complex endowed with the 
capacity to further cluster with numerous 
additional cdl surface and cytoplasmic mole-
cules. There is an ever-growing number. cur-
rently close [0 600. of known MHC alleles. 
each endowed with an individu.uized peptide 
binding motif. There are 166 recognized CD 
molecules. ie .. defined cell surface molecules 
associated with leukocyte differentiation. 
There are nearly 20 official Interleukins. each 
with multiple. 50metimes- overlapping func-
tions. and each with one or more differenti.u-
Iy expressed receprors. There are numerous 
additional cvtokines with immunologic 
importance. including at least a dozen 
chemokines and a dozen more tissue 
growth factors. Each of these also have 
one or more differentiallr expressed 
receptors. Finally. there are multitudes 
of intercdlular adhesion molecules (at 
least 20 in the integrin fllmily alone) 
that play major roles in leukocyte 
mobilization and activation. 
To make marrers worse. T cell 
function has become much more 
complicated. Helper cells can be 
cytotoxic. sometimes. and both 
helper and cytotoxic T cells produce 
cytokine~ that can help some immune 
responses and. on occasion. suppress 
others. CD4 + T cells have been divided 
into ThO. Th I. Th2. and recentlyTrl fun-
ctional subsets. with more subsets sure to be 
identified in both the CD4+ and CDS' popu-
lations. Each of these different T cell subsets 
produce different arrays of lymphokines. The 
Iymphokines. either individually or in various 
combinations. act to influence the phenotype 
and function of their companion leukocytes. 
and of the local parenchymal cells. In turn. 
leukocytes and parenchymal cells make differ-
ential arrays of chemokines. which. among 
other things. work in various combinations to 
induce distinctive patterns of adhesion mole-
cule expression on one other. Chemokine 
activity is mediated by chemokine receptors. 
which are displayed. again in various combi-
nations. by many different cell types. under 
the control. to some degree. of specific lym-
phokines. In turn. the pattern oflymphokine 
production by T cells is dependent on the 
encounter of specific cytokines andlor adhe-
sion molecules during TcR engagement. It 
should come as no surprise that this vast tan-
gle of known molecular and cellular interac-
tions has not been assembled into a coherent 
mechanism that explains any of the basic 
forms of .ulograft rejection. 
What has emerged from the years of srudy 
on the mechanisms of .ulograft rejection. and 
other immune pathologies in general. is not 
the anticipated understanding of specific 
pathologic mechanisms, but an increasing 
awe at the mind-boggling complexity of 
immune responses. This complexity is so pro-
found and pervasive that it has become the 
general practice to actively ignore it. The scope 
of this complexity is just too broad for the 
human mind to grasp in itS entirety. Thus, 
sanctioned oversimplification is practiced. 
juSt to permit coherent discussion of issues. 
and the formulation of practical experiments. 
I propose that-it js this sanctioned oversim-
plification of immune complexity that has 
subvenc:.~ our attempts to understand any of 
thc 
mecha-
".' . 
nisms of allo-
graft 
'1-r '" 
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graft rejection or .ulograft tolerance. I believe 
that complexity is an integral and formative 
element of the biologic system under study. 
and attcmpts to understand the system 
abstracted from its complexity arc, in my 
opinion. doomed to continued f.Ulure. Byanal-
ogy. I doubt that we .could describe a misty 
waterfall. a raging blizzard or a brilliant rain-
bow. based solely on the even the most rigorous 
analyses of the physical structUre of individual 
water molecules. These functions of watcr are 
phenomena that emerge only under a complex 
array of specific physical conditions. A:; scien-
tists. we have trained ourselves to look down. 
and not up. to watch where we step. but not 
where we are going. In some ways, we have 
been seduced by our own scientific mythology. 
We have taught ourselves to believe that com-
plex systems function as the sum of their parts. 
and that an understanding of a system can be 
achieved by the ever morc careful analysis of its 
dissected components. But what if this premise 
is incorrect? 
Paradigm shift 
Why are these biologic systems so incredi-
bly complex? Isn't such complexity error-
prone? What. then. is the biologic value that 
preserves such complexity? Most impottantly. 
how do we. as investigators. deal with the awe-
some complexity of these biologic systems? 
I have been thinking about these questions 
for some time. and for the remainder of this 
talk. I would like to discuss some of the 
answers that I have arrived at. In general. I 
find these answers to be both exhilarating. 
because they stir the scientific spirit. and 
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frightening. because they flaunt the well-en-
trenched and powerful scientific status quo. 
In short. we do as a few others have done 
before us when confronted with informatlon 
that persistently refuses (0 conform with the 
accepted pattern of contemporary thought. 
we develop a new paradigm. And when the 
conceptual shift is severe enough. we under-
take that most creative of human endeavor~ 
so elegantly discussed by Thomas Kuhn is his 
classic treatise. "Tht StruCfUr( of Scimrrjic 
Rtvolutiom". In his words. scientific revolu-
tions occur' when "we can no longer evade 
anomalies that subvert the existing tradition 
of scientific practice- then begin the extraor-
dinary investigations that lead the profeSSIOn. 
at last. (0 a new set of commitments. a new 
basis for the practice of science." 
I believe that a growing appreCiation tor 
biologic complexity has led us (0 the brink of 
such a scientific revolution. Further. I believe 
that the opening events of this revolutIOn. 
the first of Kuhn's "extraordinarv Investlga· 
tions". have already been undertaken. These 
by a committed group of far-sighted and 
creative intellectuals working through the 
Santa Fe inS(itute (0 ourline the prImarv tea-
tures of what they call chaos or complexuy 
theory. Over the last several years. thev have 
begun to apply this theory to a diverse array 
of biologic. sociologic lnd economic 
systems. I will warn you thlt thei r view-
points and arguments can be intellectuallv 
enchanting. I also warn you that accepting 
their arguments will catapult you Immedi-
ately to the extreme boundaries of scientltic 
thought and procedure. lnd will change for-
ever the wav you perceive the problems that 
you address in your discipline:. Unforru-
nately. a discussion of the pioneers and of 
complexity theorv. its fascinating conceptual 
development. is well bevond the scope of 
this talk. For this. I recommend ~everal 
excellent books. including Chaos. by James 
Gleick . Thr Wrb of Lifr. by Fritiof Capra. 
and mv personal favorite. Our of Control 
hv Kevin Kelk . 
Towards embracing 
complexity 
What I would like to do with mv remaining 
time. is (0 oudine for you.an application of 
complexity theory to transplant immunobiol-
ogy. I offer this as a plausible alternative (0 the 
current working paradigm. As such. it does 
not contest anv of the experimental data accu-
mulated thus far. it merdy provides an differ-
ent perspective for interpretation of these data. 
Ie .. an alternative conceptual framework. In 
dn effort to better understand the processes of 
chronic rejection and tolerance. I have been 
exploring network theory for the last two-to-
three years. and have. in fact. included some 
discussion of network theory in a few recent 
review articles. I ask you [0 remember that 
this conceptualization is very much a work in 
progress. I ask you also to view these some-
what radical concepts with an open mind. and 
to consider how they might. if accurate. 
change your understanding of important 
issues in your trade. be it basic re-search. clin-
ICal research. or clinical practice in the field of 
rransplantation. 
To begin with. it is imponant to appreciate 
that the immune system is a special type of 
networked system. Since the days of Dick Ger-
shon. immunologists have generally accepted 
r he network concept. but few have peered 
beyond the simple network imagery. and con-
Sidered the profound implications of a net-
worked immune system. This special type of 
network has been referred to by Kapra as a 
complex. adaptive system. defined as an aggre-
gate of diverse dements with extensive cross-
connections that displays twO special proper-
ties: it maintains coherence under change. and. 
it is capable of adaptation and learning. I will 
diSCUSS how the immune svstem exhibits each 
of these properties a little later. 
FirSt. I would like to explore complex. 
adaptive SYstems a little further. As good 
examples of complex adaptive systems. think 
of colonies of ants or bees. (To me. the 
Immune system takes on a completely differ-
ent character when I compare leukocytes to 
ants). The colony is a collection of 
JUtonomous members. each acting individu-
allv. insect-like. according to a set of internal 
rules. and to signals provided by the local 
environment. Each member is connected to 
each other in a peer network. This network 
functions effectively to perform tasks without 
central authoritv or control. Rather. actions 
.He gUided bv a web-like. non-linear causalin' 
of peers mf1~encmg peers. In such a svstem. 
the mdividual elements have no recognized 
I ndlvidualitv. and although their behaVIOr 
can be complex and unpredictable. all act 10 
.1 coord mated fashion to maintain the cmical 
functions of the colony. Such systems are 
fundamentallv inhuman. The,' arc careless 
abOUt the needs or ri~hts of the individuals. 
who are considered insignificant and expend-
able for the sake of the colony. 
What are the advantages of such a svstem? 
There are several. The colonv is highly adapt/I-
bit. and although individuals may die or chan-
ge as a result of new conditions. the colon~' 
persists. The colony is tvolvablf. since its adap-
tability permits the accumulation of change. 
The colony is rtsilimt. since multitudes of 
individuals. operating redundantly and in par-
allel. can accommodate small failures of other 
individuals. Funhermore. the colony supports 
countless novel possibilities. hidden in the 
exponential combinations of variously linked 
individuals. These possibilities provide a reser-
voir of alternative responses in times of stress. 
There are. of course. some disadvantages. The 
colonies operate intjficimtly. due to redundan-
cy and lack of central control. and they are 
prone to non-prtdictable outcomes. known in 
the business as emergent behaviors. For exam-
ple, we have already discussed some of the 
emergent behaviors of water. However. the 
worst disadvantage for the investigator is the 
fact that networked systems are basicallv 
inscrutable. Since causality is spread laterally 
throughout the network. both the triggering 
stimuli and the specific patterns of the respons-
es are obscured. Does this sound at all familiar? 
Systems thinking 
Now we come to the core of the paradigm 
shift. the conflict between analytic thinking 
and sysum! thinking. Analytic thinking. the 
ever more sophisticated analyses of funda-
mental constituents. is the cornerstone of 
modern sciemific thought and practice. Sys-
tems thinking is its complete antithesis. In 
systems thinking. the properties of the pam 
do not necessarilv define the properties of the 
system. Indeed the properties of the system 
can be understood only in the context of its 
larger whole. ie .. when complexity is intact. 
Clearly. this concept is foreign to classically-
trained scientists. like myself. Interestingly. I 
find that the concept is not so foreign to 
• Shift from importance of elements to 
importance of organizational pattern 
(configuration of relationshIps Is 
characteristic of a particular system) 
• Patterns cannot be measured or 
weighed, they must be mapped 
• System properties arise from the specific 
configuration of ordered relationships 
• To appreciate biologic mechanism, need 
to identify patterns of elements, not 
just elements themselves 
physicians. who eventuallv adopt svstem~ order out of apparent chaos. Because of scaf-
thinking from long empirical experience with folding. large numbers of inflammatory 
the complex adaptive svstems represented bv response components can be stockpiled at 
the phvsiologies of their own patients. Small inflammatorv sites. each to be used onlv if 
wonder that. historicallv. there has been some and w~en appropriate. Finally! s,;affolding 
degree of intellectual friction between phvsi- permits so-called subsumption contro\' ie .. a 
~. 'q..-- .-
cians and scientists. m~ swi,tch tha~can alter enure response 
Let us consider. then. how sYStems thinking programs. For exam~TGF~ generally acts 
and complexity theory impact transplant-relat· to IUbvert immune responses. but to promote 
ed research. How do these concepts apply to tissue rem~deling responses. This phenome-
biologic webs. and especiallv to those biologic n~n h;;-recently gained much attention in 
webs that operate in transplant recipients? several experimental models of immunologic 
First. it is clear that the biologic responses tolerance and chronic allograft rejection. 
to injury. ie .. inflammation. immunltv and The second network principle isparaiki pro-
tissue repair. are complex. integrated networks cming.ln essence. the system employs all avail-
of interacting elements. Because thev are net- able response mechanisms simultaneously. The 
worked. they can accommodate error or miss- actual degree to which each mechanism partic-
ing elements. In addition. they provide many ip~tcs'G, of course, governed by a number of 
alternative response options to a perturbation. variables. including the nature. location and 
This networked interaction design provides a amount 'of antigen. It is also governed by the: 
much higher survival value than a linear in~~~c inflammatory factors that are 
action design. where error or interference at either contributed to the stockpile. or 
any link can disrupt the entire system. Never- removed. by any of the other response compo-
theless. it is interesting to note that virtuallv nents. However. it is important to note that 
all of our current depictions of immune there is no central control of these responses as 
response pathwavs are displayed as maps of they are constructed de novo at a graft site. and 
linear interactions. that only the presence or absence of antigen 
If networks provide so many options. how. influences the propagation of the various 
then are networks controlled? This is the core response processes. The redundancy of parallel 
problem --;'ith complexity theorv. In general. I processing makes it somewhat inefficient. but 
believe that control of networked systems insures its effectiveness. I believe that parallel 
stems not from the manipulation of selected processing is one reason why IL2 or IFNy 
network elements. but from the shepherding knockout-mice retain the perplexing ability to 
of network response patterns. I submit that mount effective graft rejection responses. 
there are. in fact. several effective approaches The th1rd important network pci~c:iple is 
to network COntrol. These are best understood dYll'H1lic~nia.gtmtnt. ·i~ .• the continuous 
within the context of basic nerwork princi- arrival and departure (or death) of response 
pIes. of which there are four that bear discus- participants. In healthy individuals. the 
sion. I will refer to these principles as Phvlo- immune system has an almost inexhaustible 
genic Layering. Parallel Processing. Dynamic supply of participants which it can throw at 
Engagement and Variable ConnectlVlry. any task. This is why clonal deletion is diffi-
Network regulating 
mechanisms 
cult to achieve in adult animals. Graft-reactive 
Iymphocvtes are abundant and widely distrib-
uted in an allograft recipients. and onlv a frac-
tion of these become active participants in a 
given rejection response. The rest remain in 
reserve at depots throughout the body. Even 
the most efficient deletion of antigen-activat-
ed T cells. unless quite prolonged and sys-
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temic. will not result in the clonal deletion of 
graft-reactive T cells. There are twO major 
advantages to dynamic engagement. a) it 
allows the immune responses to be inherently 
self-limiting. and b) it allows the continuous 
monitoring by the immune system of antigen 
persistence or elimination. I suggest that 
dynamic engagement is the context in which 
most programmed cell death. apoptosis. actu-
ally occurs at inflammation sites. The alterna-
tive mechanism. leukocyte departure. is pre-
sumed to occur. but has been largely over-
looked by immunologists. I am not aware of 
any reportS on the length of time that individ-
uallymphocytes actually spend at a site of 
inflammation. Further. the mechanisms by 
which lymphocyte might leave these sites are 
not even under consideration by investigators. 
The final. and perhaps most interesting 
principle of network function is variabk con-
ntctivity. It is intuitively obvious that tOO lit-
tle connectivity between network members 
reduces network options. and too much con-
nectivity locks up the system. so biologic net-
works must function at some intermediate 
level of connectivity. In fact. this offers a 
The fl rst of these. p~/ogrn/C la:'I~ring. is a 
basic tenant of developmental biology.jn 
Cl~nce. n~mechanisms are built on top of 
older. more primitive mechanisms. The pri-
mary advantage of this lavered pattern is the 
accumulation of multiple default responses. 
each of which has a proven track record)n. 
effec~ older mechanisms provide a scaf-
foLdi~p'~n which the newer me~~anisms 
can be assembled. Of importance is the fact 
':laiii'-:'" i.i , ia Ii i,.>II 
-,-that the assembly of the newer mechanisms 
can then be controlled by manipulation of 
these older scaffolding elements. I believe that 
this concept explains whv George Kupiec· 
Weglinski can interfere with experimental 
acute rejection by treating a1logratt reCIpients 
with the CS 1 peptide. an integrin·binding 
fragment of the pro-inflammatorv. proVision-
al matrix molecule. fibronectin. Also of 
importance. the scaffolded assemblv svstem 
insures the programmed. sequential develop-
ment of responses. This generates slgnirlcant 
1) Back-up responses 
• proVIdes mOil! pnmatlV'e. but efjIrtivP defuult II!sponses 
2) Scaffold requirements (ex. provisional 
matrix) 
• II!5pOrlSe depends on pll!Sl!OO! of cJraperone components 
3) Programmed sequential developement 
· sequence alteratron changes outcome 
- resource stockpiles allowable 
4) Subsumption mechanisms: override of 
earlier responses . (v:s. TGill) 
1) Panorama of responses governed by 
nature. location and amout of antigen 
2) No central control of response pattern 
(presence of absence of onhgen controls all) 
3) Hierarchies of effectiveness 
and effidency 
4) Responses may operate independently. 
or some may cross reguLate others 
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mechanism by which network functIon can 
be regulated. ie .• by controlling of the degree 
to which the network's members are intercon-
nected. In some ways. the exact nature of each 
connection is less important than the overall 
degree of connectivity among network mem-
bers. This. again. is systems thinking. rather 
than analytic thinking. 
All networks in complex adaptive svstems 
strive for homeostasis. For each network 
member. this homeostatic identity is defined 
in reference to its neighbors. By increaSIng 
connectivity after a perturbation. the refer· 
encing of the neighbors is enhanced. We are 
all familiar with many of the immune net-
work connectors. We know them as the pro-
inflammatory cytokines. chemokines and 
adhesion molecules that show up during acute 
rejection. I suggest that network connectlvirv 
is the basic context in which the mind-bog-
gling array of interacting immune and inflam-
matory mediators actually operate. 
Too much connectivity is bad. since hyper 
connectivity could freeze the network into a 
state of non-responsiveness and block the re-
establishment of homeostasis. I believe that 
there are a whole series of biologic discon-
nectors that act to counterbalance the con-
nectars. If so. the maintenance of homeosta- imbedded within a network of networks. One 
sis must reflect a constant. dynamic rebalanc-
ing of connectors and disconnectots. I believe 
that we also know many of these immuno-
logic disconnectors. although we rarely think 
of them as such. Among them are generalized 
dlsconnectors like steroids. TGF~ and ILl O. 
There are also specific disco.nnectors like ILl 
receptor antagonist. Ever wonder why there 
are shed ICAM-! and VCAM-! molecules. 
or shed MHC molecules? What about the 
multitudes of soluble cytokine receptors. 
chemokine receptors and growth factor 
receptors that appear during immune 
responses? In general. the immune system 
doesn't seem to like too many free connectors 
or disconnectors. 
There are some interesting additional facets 
of network connectivity. For example. I view 
immunosuppressive drugs as artificial discon-
nectars of the immune network. Perhaps. we 
should carry this idea further. and learn to 
harness the natural mechanisms of connec-
tor/disconnector production. Because of net-
work considerations. I suggest that we focus 
not on individual connectors or disconnec-
tors. such as a specific lymphokine. but on the 
regulators of broad-scale genetic programs. 
such as the NF-kB system. Alternatively. we 
could selectively mobilize the natural discon-
nectors. Perhaps this is the fundamental prin-
ciple behind the endothelial protective genes 
described over the last year or two by Chris-
tiane Ferran and Wayne Hancock. 
A really interesting application of network 
connectivity involves immune tolerance. 
What if the immune system exploits network 
hyper-connectivity for this purpose? If the 
Immune system decides to accept a new 
chemical. it must weave it into the existing 
network fabric. What better way to do this. 
t han to mobilize a paralyzing array of antigen-
specific immune responses. Perhaps this is the 
basic principle behind the phenomenon of 
infectious tolerance that has been described 
over the last few years by Herman Waldman. 
Finally. I suggest that there are both inter-
and intra-network connections. ie .• that the 
immune system is a network of networks 
':i:'ii:;;:,j,",., i i) h:;';,', 
of those broader networks is systemic physiol-
ogy. We need to remember that immune 
responses are. by themselves, perturbations of 
homeostasis in the cardiovascular system. and 
that these perturbations have ripple effects 
that can influence the physiologic functions 
of tissues and organs. Perhaps this explains 
Nick Tilney's observations that transient tam-
pering with organ perfusion eventUally results 
in chronic rejection-like vascular remodeling. 
whether the organ is transplanted or not. 
Transplant immunobiology 
revisited 
Aside from these esoteric and somewhat 
philosophical considerations. network theory 
and systems thinking have immediate appli-
cation to current. everyday transplant 
research. I suggest that an imponant role of 
the early pro-inflammatory response is to stock-
pile components for possible use during sub-
sequent immune and repair responses. 
Indeed. these responses can proceed only 
using specific components that have been 
stockpiled in this manner. For genetic or 
pharmacologic reasons. the same components 
are not always stockpiled in different individ-
uals. nor are the components necessarily used, 
even when they are available. Thus. is should 
come as no surprise that the time-honored 
analytic approach of cataloging all the com-
ponents present at a given immune response 
site has been relatively uninformative. and 
probably should be discouraged. or at least 
de-emphasized. Because of networking, there 
is probably no single mechanism of acute 
rejection. Instead. there could be as many dif-
ferent mechanisms as there are pathways 
through the networks. This accounts for the 
common observation that the various inbred 
strains of mice can respond quite differentlv 
ro contact with the same antigenic stimuli. 
Just because the activities of the damage 
response networks are complex. doesn't mean 
that they are random. disordered or chaotic. 
Quite the contrary. the network functions as 
an ordered evolution of events. in which com-
plexity merely provides options (I remind you 
of'the scaffold concept). Since these options 
are inregral to the response process. thr procm 
cannot br aCCUTaft~V Jtudird whm _~irv [J 
minlmiud. T~ i~ s~~~i~!0~~d it 
r~~c.enrral proble!.1.l-~jth in .vit~<? s~ud· 
ies. Most in Vitro studies strive to minimizing 
experimental variables. an in so doing they also 
minimize response options. Nor surprisingly. 
this results in repeatable outcomes. However. a 
similar outcome may never be observed in 
vivo. when the intact network is operating. 
The error lies in the assumption that any 
response that occurs in vitro will necessarily 
occur in vivo. In contrast. systems thinking 
suggests that in vitro studies should start with 
minimal complexity. to establish baseline cell 
behavior patterns. and then incrementally add 
new elements. eventually to reconstruct the 
actual in vivo conditions. The intent should be 
to see how the functions of the cells under test 
are altered by the new. more informative local 
environment. However. there must always be a 
reality c~:"f'here is no reliable substitute for 
the original. networked s}'$tem. Here. more 
than ever. in 111110 IImtas. 
My growing appreciation for the subtleties 
of nefWOrkeCl r.:nmunity has made me com-
fortable a perspective on immune function 
that differs somewhat from that of my fellow 
immunologists. For example. I now believe 
that categorizing T cell subsetS by their func-
tional capacities. ie .. TH 1 vs TH2. is some-
what improper and misleading. I believe that 
the only reliable subcategories ofT cells are 
CD4 vs. CDS. These markers. which defme 
the type of MHC molecule that the T cR can 
work with. determine whether the T cell mon-
itors the intracellular or the extracellular envi-
ronment. Beyond that. I believe that T cell 
function is highly variable. and depends from 
moment to moment on the panorama of sig-
nals provided bv whatever micro environment 
they happen to occupy. and. to some degree. 
on their history with specific antigen. These 
environmental signals are sensed througn a 
massive array of receptors. many of which we 
now know as CD antigens. I believe that T 
cells integrate all of this information into dis-
crete responses. It is important to remember 
that the TcR is but one of a multitude of 
receptors on T cdls. and that. In fact. the TcR 
is rardy if ever used by most T cells. Yet all T 
cells routinely change their behavior as they 
move through different compartments of the 
body. They do this via mechanisms that are 
completely independent ofT cR function. and 
arc generally ignored by most immunologists. 
I believe that every location 10 the body 
that can be occupied by T cells is so laden 
with specific information that the T cells 
know at all times exactlv where thev are. what 
is happening locally. and what. if anvrhing. 
they are supposed to do about it. This infor-
mation IS continuously provided bv vascular 
cells and parenchymal cells via their displays 
of cvtokines and adhesion molecules. If the 
TcR is engaged. it merely provides a new con-
sideration for T cells that is factored into its 
evaluation of the local environmenr. In gener-
al. I think that the T cR is highly over-rated. 
So. too. in my opinion is the conc.ept ofT cell 
anergy. which I consider [0 be the penulti-
mate in vitro-fact. I carr conceive of no loca-
tion in the body where a T cR can be engaged 
in the complete absence of any of the known 
costimularory signals. 
I believe that our interpretation of CTL 
function has been fundamentally incorrect. I 
tnink that CTL. and T cells in general. play 
linle or no direct role in the destruction of 
graft tissues. Rather. I believe that they func-
tion through cytokines and cell-surface mole-
cules to orchestrate the powerful and danger-
ous destructive mechanisms mediated by 
macrophages. NK cells and other leukocyte 
populations. I believe that CTL. which are 
known to be efficient at killing other leuko-
cvtes. but relatively inefficient at killing 
parenchymal cells. serve primarily as immune 
disconnectors at inflammatory sites where T 
cells have engaged antigen. 
I believe that leukocytes are not the only cell 
types involved in immune responses. Rather. 
all cells at the site. including parenchymal 
cells. produce cytokines and adhesion mole-
cules. and thus are actively involved in a local 
immune response. Evidence for this is widely 
available. Several cytokines. like III 0 and 
TGFIJ. are known to be made by parenchymal 
cell types. but this is generally ignored. anoth-
er case of sanctioned oversimplification. By 
extension. immunity and physiology are inex-
tricably linked. since parenchymal cells are 
responsible for the physiologic functions of 
tissues. I believe that under normal conditions. 
le!t!'0cy!.~nd-parencilymal cells use 
cywlunes and adhesion molecules to chit-chat 
with the.:oselves and with each other. In times 
of ~~r~~s. these conversations simply become 
somewhat more animated. I think that if you 
could listen to the intercellular conversations 
that develop at inflammatory sites. it would 
sound less like the issuance of military com-
mands to the local militia. and more like the 
frenzied cackle of chickens in the coop when 
the fox is around. 
The end of the beginning 
In summary. I find that current experimen-
tal observations in transplant immunobiology 
have become increasingly difficult for me to 
understand within the context of current 
immunologic thought. Surprisingly. many of 
these observation become explainable. and 
even predictable .. when viewed from the per-
spective of network theory and systems think-
ing. I have no problem with this. Indeed. par-
adigm shifts are a natural and important part 
of the scientific process. However. complexity 
theory and systems thinking do not represent 
graft 
pallcl80 
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simple paradigm shifts. They represent a sig-
nificant philosophic repositioning. a radical 
departure from accepted pattern of scientific 
thought. They are the vanguard ideas of a sci-
entific revolution that could change some of 
the most basic perceptions of our discipline. 
and perhaps even of our society. They could 
force the development of entirely new pat-
terns of scientific thought. and new rules by 
which experiments are designed and imple-
mented. Like other scientific revolutions dis-
cussed so thoroughly by Kuhn. this scientific 
revolution is likely to be painful. and some-
times acrimonious process. There will be 
many casualties among the revolutionaries. 
brought down by their inability to convince 
their peers and the various funding agencies 
to support their seemingly counter-scientific 
conceptualizations and their radical, methods 
of experimentation. (I hope that this is not 
my epitaph.) In the end. however. scientific 
truth. ie .. a more accurate perception of reali-
ty. will emerge. Whether or not this reality 
happens to lie: along the path of complexity 
theory and systems thinking will be deter-
mined some time in the 21st century. In the: 
interim. I consider it to be my great good for-
rune to be a practicing scientist during one of 
the rarest. and most intellectually exhilarating 
events in all of science. a scientific revolution. 
In closing. I wish to again thank the orga-
nizers of this meeting for the opportunity to 
present these unconventional ideas in so 
prominent and prestigious a forum. I also want 
to thank you. the audience. for your patience 
with my opinions. While I may not be able to 
provide you with any clear answers. I hope at 
least. that I will leave you with some useful. 
new ideas on the nature of the problems. 
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